What is the prevalence of Methylmalonic acidemia?

Methylmalonic acidemia (MMA) is a rare metabolic disorder with an estimated global incidence ranging from 1 in 50,000 to 1 in 100,000 live births, though rates vary significantly by region and population. Because many cases are detected through newborn screening programs, the true prevalence is difficult to ascertain, and it is classified as a rare disease worldwide.

What is the estimated incidence and prevalence of Methylmalonic acidemia?

The incidence of Methylmalonic acidemia varies globally based on the specific genetic subtype and the efficacy of local newborn screening programs. According to the NIH Genetic and Rare Diseases Information Center (GARD), the estimated incidence is approximately 1 in 50,000 to 1 in 100,000 births. However, in certain populations where consanguinity is more common, the frequency of Methylmalonic acidemia can be significantly higher. Because this is a life-long metabolic condition, prevalence figures reflect both new diagnoses and individuals living with the disease, many of whom may face chronic health challenges into adulthood.

Does Methylmalonic acidemia affect genders or age groups differently?

Methylmalonic acidemia does not show a predilection for one gender over the other; it affects males and females equally. Regarding the age of onset, the condition is primarily identified in the neonatal period, often presenting with severe metabolic acidosis, vomiting, and lethargy shortly after birth. However, there are "late-onset" or "mild" forms of Methylmalonic acidemia that may present in infancy, childhood, or even early adulthood. These later presentations are often associated with partial enzyme activity, which may lead to a delay in diagnosis compared to the classic neonatal form.

Are there geographic or ethnic variations in the occurrence of the disease?

While Methylmalonic acidemia is considered a pan-ethnic condition, specific genetic mutations are more prevalent in certain geographical regions. For example, specific mutations are found more frequently in populations of Middle Eastern or North African descent. It is important to note that these statistics are estimates, and the actual number of individuals living with Methylmalonic acidemia is likely higher due to:

• Underdiagnosis: Mild or late-onset forms may be missed if newborn screening is not comprehensive.


• Misdiagnosis: Symptoms like failure to thrive or developmental delays can sometimes be attributed to other conditions before a metabolic workup is performed.


• Limited Data: Many regions lack centralized registries, making it difficult to track every individual with the condition.

How does the DiseaseMaps community reflect the experience of this condition?

The DiseaseMaps.org community currently includes 54 people living with or caring for someone with Methylmalonic acidemia. This real-world data provides a vital, human-centered perspective that complements clinical statistics. While medical literature focuses on incidence rates and genetic markers, the community data highlights the diverse, lived experience of those navigating the daily complexities of metabolic management, dietary restrictions, and long-term health monitoring.

Next steps

• Consult with a metabolic specialist or a clinical geneticist to discuss genetic testing and family planning options.


• Connect with the 54 members of the Methylmalonic acidemia community on DiseaseMaps.org to share experiences and coping strategies.


• Ensure that you or your loved one is registered with a national metabolic disease registry to assist in global research efforts.


• Regularly review new clinical trials and research updates via the NIH GARD portal.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Methylmalonic acidemia overview.


• Orphanet: Prevalence of rare metabolic diseases (ORPHA:576).


• OMIM (Online Mendelian Inheritance in Man): Entry #251000 regarding Methylmalonic Aciduria.


• Journal of Inherited Metabolic Disease: Clinical guidelines for the management of methylmalonic acidemia.